Picton Mahoney Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Buy |
714,613
+117,756
| +20% | +$1.97M | 0.12% | 145 |
|
|
2025
Q1 | $9.17M | Sell |
596,857
-36,292
| -6% | -$558K | 0.16% | 115 |
|
|
2024
Q4 | $14M | Buy |
633,149
+213,041
| +51% | +$4.69M | 0.28% | 60 |
|
|
2024
Q3 | $7.57M | Buy |
420,108
+221,608
| +112% | +$3.99M | 0.25% | 118 |
|
|
2024
Q2 | $3.23M | Buy |
+198,500
| New | +$3.23M | 0.13% | 169 |
|
|
2017
Q1 | – | Sell |
-14,100
| Closed | -$510K | – | 213 |
|
|
2016
Q4 | $510K | Hold |
14,100
| – | – | 0.04% | 150 |
|
|
2016
Q3 | $648K | Sell |
14,100
-62,050
| -81% | -$2.85M | 0.04% | 174 |
|
|
2016
Q2 | $3.83M | Sell |
76,150
-41,740
| -35% | -$2.1M | 0.24% | 105 |
|
|
2016
Q1 | $6.31M | Sell |
117,890
-8,169
| -6% | -$437K | 0.4% | 80 |
|
|
2015
Q4 | $8.28M | Buy |
126,059
+74,359
| +144% | +$4.88M | 0.49% | 70 |
|
|
2015
Q3 | $2.92M | Buy |
+51,700
| New | +$2.92M | 0.17% | 112 |
|
|
2013
Q3 | – | Sell |
-76,900
| Closed | -$3.02M | – | 365 |
|
|
2013
Q2 | $3.02M | Buy |
+76,900
| New | +$3.02M | 0.22% | 112 |
|